Project Details
Description
Development of MD-1 & MD-6 for HIgh Risk Triple Negative Breast Cancer Treatment
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/14 → 12/31/14 |
Funding
- Whiteside Inst. for Clinical Research
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.